MedTrace Logo

T-regulatory Cells in Diabetic Type Two Nephropathy

NCT03591939 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2018-07-19

No results posted yet for this study

Summary

Diabetes mellitus is one of the most prevalent health problems worldwide. Diabetic nephropathy has become the leading cause of end-stage kidney disease worldwide and is associated with an increased cardiovascular risk.

Traditionally, metabolic and hemodynamic factors are the main causes of renal lesions in patients with type two diabetes mellitus and diabetic nephropathy , both considered non-immune diseases. Serial researches has demonstrated that diabetic nephropathy is a metabolic and hemodynamic disorder, with inflammation playing a vital role in the process.

Conditions

  • Diabetic Nephropathy Type 2

Interventions

DIAGNOSTIC_TEST

laboratory test

role of T- regulatory cells in the patients of diabetic nephropathy

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-08-01
Completion
2019-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03591939 on ClinicalTrials.gov